Clinical Trial Update: Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District [Phase 2]

View source ↗

Summary

Phase 2 trial update on accelerated modulated fractionation (SIB-IMRT) for head and neck carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma of the Head and Neck

Snippet

Sponsor: European Institute of Oncology | Conditions: Carcinoma of the Head and Neck | Phase 2 | Status: UNKNOWN